SCOPE2: A Platform for Sars-COv-2 Primer covErage Evaluation

Currently, there is an increasing number and speed of SARS-CoV-2 mutation taking place around the world, posing a threat to promising public health and challenge to existing diagnostic tools. RT-PCR technology is recognized as the gold standard diagnosing methodology but has shown inaccuracy under some mutated SARS-CoV-2 circumstances. In this study, we developed a platform named SCOPE2 (Sars-COv-2 Primer covErage Evaluation) based on our previous publication. Testing by commonly-used SARS-COV-2 PCR primers, SCOPE2 is proved to effectively and efficiently assess the quality in terms of detection coverage, which may provide a practical tool for primer selection acceleration and primer design improvement.Clinical Relevance—This assists in single SARS-COV-2 Primer selection and suggestion of different SARS-COV-2 Primer combinations.

[1]  T. de Oliveira,et al.  Appropriate names for COVID-19 variants , 2021, Science.

[2]  C. Ascoli.  Could mutations of SARS-CoV-2 suppress diagnostic detection? , 2021, Nature Biotechnology.

[3]  Zhènglì Shí,et al.  Characteristics of SARS-CoV-2 and COVID-19 , 2020, Nature Reviews Microbiology.

[4]  K. Korn,et al.  SARS-CoV-2 samples may escape detection because of a single point mutation in the N gene , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[5]  E. Callaway.  The coronavirus is mutating — does it matter? , 2020, Nature.

[6]  Devy M. Emperador,et al.  Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis of SARS‐CoV‐2 infection , 2020, The Cochrane database of systematic reviews.

[7]  Shan X. Wang,et al.  Diagnostics for SARS-CoV-2 detection: A comprehensive review of the FDA-EUA COVID-19 testing landscape , 2020, Biosensors and Bioelectronics.

[8]  Luis Peñarrubia,et al.  Multiple assays in a real-time RT-PCR SARS-CoV-2 panel can mitigate the risk of loss of sensitivity by new genomic variants during the COVID-19 outbreak , 2020, International Journal of Infectious Diseases.

[9]  Po-E Li,et al.  A public website for the automated assessment and validation of SARS-CoV-2 diagnostic PCR assays , 2020, Bioinform..

[10]  Rhiju Das,et al.  RNA genome conservation and secondary structure in SARS-CoV-2 and SARS-related viruses: a first look , 2020, RNA.

[11]  Anna María Nápoles,et al.  COVID-19 and Racial/Ethnic Disparities. , 2020, JAMA.

[12]  Meei-Li W Huang,et al.  Comparison of Commercially Available and Laboratory-Developed Assays for In Vitro Detection of SARS-CoV-2 in Clinical Laboratories , 2020, Journal of Clinical Microbiology.

[13]  Colin Renfrew,et al.  Phylogenetic network analysis of SARS-CoV-2 genomes , 2020, Proceedings of the National Academy of Sciences.

[14]  Victor M Corman,et al.  Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[15]  W. Cai,et al.  MFEprimer-3.0: quality control for PCR primers , 2019, Nucleic Acids Res..

[16]  Ola Spjuth,et al.  SciPipe - A workflow library for agile development of complex and dynamic bioinformatics pipelines , 2018, bioRxiv.

[17]  Yuelong Shu,et al.  GISAID: Global initiative on sharing all influenza data – from vision to reality , 2017, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[18]  Alexandre Masselot,et al.  Visualization of protein sequence features using JavaScript and SVG with pViz.js , 2014, Bioinform..

[19]  Yi Yang,et al.  MFEprimer-2.0: a fast thermodynamics-based program for checking PCR primer specificity , 2012, Nucleic Acids Res..

[20]  Carl T. Wittwer,et al.  Monovalent and divalent salt correction algorithms for Tm prediction - recommendations for Primer3 usage , 2011, Briefings Bioinform..